Back to results
US 2002/0161528 A1Published application
Tool for lipophilicity determination in drug discovery basic and neutral compounds
AssigneePfizer Inc.
InventorsFranco Lombardo, Marina Yevgenievna Shalaeva, Karl Andrew Tupper
Life of this patent
Estimating the term…
Abstract
A RP-HPLC method for the determination of ElogDoct values for chemical compounds from retention time of each sample of the compound using (EQ1) drop in equation. This method has been shown to be effective on a set of 90 molecules.
Claims6
A method of determining ElogDoct for chemical compounds which comprises:
- a. Introducing said chemical compounds seriatim to the column of a reverse phase high performance liquid chromatographic system said column being an embedded amide functional group column;
- or a C-18 bonded column with low silanol activity;
- and
- b. Eluting said compounds with a mobile phase containing MOPS buffer and a methanol/octanol mixture in which the proportions of said methanol/octanol mixture to said buffer are from 75 to 15% v/v;
- and with flow rates between 0.5 and 3 ml/min and
- c. Measuring the retention time required to elute each sample from said column;
- and
- d. Calculating ElogDoct from the retention time of each sample using equation 1:
- logDoct=1.1267 (±0.0233) log k′w+0.2075 (±0.0430) (Eq. 1).
6 more elements
Dependencies are inferred from the claim text.